» Articles » PMID: 1544873

The Protective Role of Glutathione, Cysteine and Vitamin C Against Oxidative DNA Damage Induced in Rat Kidney by Potassium Bromate

Overview
Specialty Oncology
Date 1992 Jan 1
PMID 1544873
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The roles of glutathione (GSH), cysteine, vitamin C, liposome-encapsulated superoxide dismutase (L-SOD) and vitamin E in preventing oxidative DNA damage and cytotoxicity in the rat kidney after administration of potassium bromate (KBrO3) to male F344 rats were investigated by measuring 8-hydroxydeoxyguanosine (8-OH-dG), an oxidative DNA product, lipid peroxidation (LPO) levels and relative kidney weight (RKW). Combined pre- and posttreatment of animals with 2 x 800 mg/kg GSH i.p. inhibited the increase of 8-OH-dG, LPO levels and RKW caused by 80 mg/kg KBrO3 i.p. administration. In contrast, pretreatment with 0.3 ml/kg diethylmaleate (DEM) i.p., a depletor of tissue GSH, was associated with elevation of 8-OH-dG, LPO levels and RKW after a 20 mg/kg KBrO3 i.p. treatment, which itself caused no change. Administration of KBrO3 itself reduced renal non-protein thiol levels, but this was inhibited by the two doses of exogenous GSH. Combined treatment with DEM and KBrO3 lowered the non-protein thiol level in the kidney more than did DEM treatment alone. Protective effects against the oxidative damage caused by KBrO3 were also observed for pre- and posttreatment with 400 mg/kg cysteine i.p., another sulfhydryl compound, and daily i.g. application of 200 mg/kg vitamin C for 5 days. However, no influence was evident after pre- and posttreatment with 18,000 U/kg L-SOD i.p. or daily i.g. 100 mg/kg of vitamin E for 5 days. The results suggest that intracellular GSH plays an essential protective role against renal oxidative DNA damage and nephrotoxicity caused by KBrO3.

Citing Articles

New aspects in deriving health-based guidance values for bromate in swimming pool water.

Rohl C, Batke M, Damm G, Freyberger A, Gebel T, Gundert-Remy U Arch Toxicol. 2022; 96(6):1623-1659.

PMID: 35386057 PMC: 9095538. DOI: 10.1007/s00204-022-03255-9.


Proteome Damage Inflicted by Ionizing Radiation: Advancing a Theme in the Research of Miroslav Radman.

Bruckbauer S, Minkoff B, Sussman M, Cox M Cells. 2021; 10(4).

PMID: 33924085 PMC: 8074248. DOI: 10.3390/cells10040954.


Blockade of Cardiac Proton Pump Impairs Ventricular Remodeling Through a Superoxide-DDAH-Dependent Pathway in Infarcted Rats.

Chen W, Shie C, Yang C, Lee T Acta Cardiol Sin. 2019; 35(2):165-178.

PMID: 30930564 PMC: 6434409. DOI: 10.6515/ACS.201903_35(2).20180917A.


Protective effects of Sonchus asper against KBrO3 induced lipid peroxidation in rats.

Khan R, Khan M, Sahreen S Lipids Health Dis. 2012; 11:164.

PMID: 23186106 PMC: 3544701. DOI: 10.1186/1476-511X-11-164.


Protective effects of rutin against potassium bromate induced nephrotoxicity in rats.

Khan R, Khan M, Sahreen S BMC Complement Altern Med. 2012; 12:204.

PMID: 23116356 PMC: 3552874. DOI: 10.1186/1472-6882-12-204.


References
1.
Kasai H, Crain P, Kuchino Y, Nishimura S, Ootsuyama A, TANOOKA H . Formation of 8-hydroxyguanine moiety in cellular DNA by agents producing oxygen radicals and evidence for its repair. Carcinogenesis. 1986; 7(11):1849-51. DOI: 10.1093/carcin/7.11.1849. View

2.
Sai K, Takagi A, Umemura T, Hasegawa R, Kurokawa Y . Relation of 8-hydroxydeoxyguanosine formation in rat kidney to lipid peroxidation, glutathione level and relative organ weight after a single administration of potassium bromate. Jpn J Cancer Res. 1991; 82(2):165-9. PMC: 5918382. DOI: 10.1111/j.1349-7006.1991.tb01824.x. View

3.
Kurokawa Y, Hayashi Y, Maekawa A, Takahashi M, Kokubo T, ODASHIMA S . Carcinogenicity of potassium bromate administered orally to F344 rats. J Natl Cancer Inst. 1983; 71(5):965-72. View

4.
Fiala E, Conaway C, Mathis J . Oxidative DNA and RNA damage in the livers of Sprague-Dawley rats treated with the hepatocarcinogen 2-nitropropane. Cancer Res. 1989; 49(20):5518-22. View

5.
. Some naturally occurring and synthetic food components, furocoumarins and ultraviolet radiation. IARC Working Group. Lyon, 15-22 October 1985. IARC Monogr Eval Carcinog Risk Chem Hum. 1986; 40:1-415. View